(Subject to change)
All times mentioned refer to British Standard/Summer Time (BST) – London/GMT+01:00. Registered delegates will be sent joining information a few days before the meeting.
World Time Converter: https://www.worldtimebuddy.com/
Presentation language: English
We have tried to group similar talks, but due to the wide geographical locations of our speakers, this may not always have been possible.
1400: Opening remarks and welcome by Drs Janjic and Mckeague
1410: Professor Bruce Sullenger
Professor, Cardiovascular Biology Laboratory, Duke University School of Medicine, Durham, North Carolina, USA
Antithrombotic Aptamers in the Era of COVID-19
1430: Dr Amy Gelinas and Mr Adam Harding
SomaLogic Inc, 2945 Wilderness Place, Boulder, Colorado, USA and Sir William Dunn School of Pathology, University of Oxford, UK
Modified DNA aptamers to SARS-CoV-2 spike protein for diagnostic and therapeutic uses
1500: Dr Zuben Sauna
Principal Investigator, US Food and Drug Administration, Silver Spring, MD, USA
Aptamers as reagents to characterize recombinant protein therapeutics
1520: Professor Maria DeRosa
Professor and Chair, Department of Chemistry, Carleton University, Ottawa, Ontario, Canada
Aptamers for Agricultural Biosensing and Delivery Applications
1540: Professor Philippe Dauphin Ducharme
Professor, Département de chimie, Université de Sherbrooke, Sherbrooke, Québec, Canada
In Brain and In Vein Detection of Antibiotics using Electrochemical Aptamer-based Biosensors
1600: Lifetime Achievement Award presentation to Professor Larry Gold (citation by Dr Nebojsa Janjic)
1610: Professor Larry Gold
1630: Break, breakout rooms, flash talks
(Flash talk presenters: Ali Askari | Micaela Belleperche | Zachary Churcher | Nusaibah Dawood | Madison Ferguson | Yunus Kaiyum | Michael Malca | Aron Shoara | Sladjana Slavkovic | Brittany Uebbing/Doru Gucer/Sheetal Mohanty)
1700: Professor Iain MacPherson
Professor, Department of Tropical Medicine, University of Hawaii at Manoa, Honolulu, USA
If you can’t beat them, join them: aptamer-mediated site-specific antibody-oligonucleotide conjugation
1720: Professor Philip Johnson
Professor of Chemistry, Department of Chemistry, York University, Toronto, Ontario, Canada
Developing cocaine-binding aptamers with multiple binding sites
1740: Dr Shengnan Xiang
Postdoctoral Scientist, Department of Bioengineering, Stanford University, Stanford, CA, USA
A multiplexed, automated evolution pipeline enables scalable discovery and characterization of biosensors
1800: Mr Sasha Ebrahimi
Graduate Research Student, Department of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois, USA
Forced Intercalation (FIT)-Aptamers
1820: Mr Serhii Hirka
Graduate Research Student, McGill University, Montreal, Quebec, Canada
DNA-encoded functionalized aptamers
1840: Closing remarks by Dr Janjic and close
0800: Opening remarks by Dr Sarah Shigdar
0810: Professor Marit Nilsen-Hamilton
Professor, Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University and Faculty Scientist, Ames Laboratory, US Department of Energy, Ames, IA USA
Structure of the Spinach aptamer/ligand complex: A moving target
0830: Dr Katsunori Horii
R&D Manager, NEC Solution Innovators, NEC Corporation, Tokyo, Japan
High-affinity DNA aptamers with base appended bases (BAB) modification
0850: Drs Magdalena Puchała and Monika Lopko
Pure Biologics S.A., Research & Development Department, Wrocław, Poland
Specific removal of anti-aquaporin-4 antibodies by aptamer-enabled adsorber device
0910: Professor Dr Beatrix Suess
Professor, Synthetic Genetic Circuits, Technical University of Darmstadt, Darmstadt, Germany
New synthetic riboswitches identified by Capture-SELEX
0930: Professor Dr Günter Mayer
Professor, University of Bonn, Life & Medical Sciences Institute (LIMES), Chemical Biology, Bonn, Germany
Dynamic changes in DNA populations revealed by split-combine click- selection
0950: Professor Ralf Jungmann
Professor, LMU Munich and Max Planck Institute of Biochemistry, Munich, Germany
Super-resolution microscopy with DNA molecules
1010: Break, breakout rooms and flash talks
1040: Dr Banushan Balansethupathy
Staff Scientist, Aptamer Group, Second Floor, BioCentre, Innovation Way, York, UK
Next-generation aptamers in the development of a rapid COVID-19 antigen lateral flow test
1100: Dr Nako Nakatsuka
Postdoctoral Scientist, ETH Zurich, Institute for Biomedical Engineering, Zurich, Switzerland
Target-Induced Aptamer Conformational Change in Nanopores Enables Neurochemical Sensing
1120: Dr Jon Ashley
Assistant Professor, Department of Healthcare Technologies, The Technical University of Denmark, Kgs. Lyngby Denmark
The molecular imprinting of protein binding aptamers
1140: Dr Anna Miodek
Aptamer Scientist, Rexgenero France, Villejuif Bio Park, Villejuif, France
Functional characterization of CD3-specific DNA aptamers
1200: Dr Tarun Sharma
Senior Research Scientist, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India
A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2
1220: Closing remarks by Dr Shigdar and close
